{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-281200","form_type":"8-K","ticker":"REVB","cik":"0001810560","company_name":"REVELATION BIOSCIENCES, INC.","filed_at":"2026-06-24T20:47:58+00:00","discovered_at":"2026-06-24T20:49:04.332088+00:00","generated_at":"2026-06-24T20:49:24.775996+00:00","sec_items":["5.02","5.03","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Revelation Biosciences adopts bylaw amendments, authorizes reverse stock split","bullets":["Board approved amended employment agreements for CEO & CFO: 2x salary+bonus severance on change in control, 18-mo COBRA, 3-year term.","Stockholders authorized reverse stock split up to 1:250 within one year, allowing Board to fix ratio without further approval.","Bylaws updated: universal proxy rule compliance, formal 'Cause' definition for officers/directors, removal only for cause due to classified board.","Elected Jennifer Carver as Class A director to serve until 2029 annual meeting; ratified Baker Tilly as auditor for FY2026.","Emergency succession framework added for CEO/CFO vacancies: CFO assumes CEO duties, CEO assumes CFO duties pending Board action."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-281200","json":"https://secwatch.observer/filing/0001193125-26-281200.json","markdown":"https://secwatch.observer/filing/0001193125-26-281200.md","text":"https://secwatch.observer/filing/0001193125-26-281200.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1810560/000119312526281200/0001193125-26-281200-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1810560/000119312526281200/revb-20260624.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T20:49:24.775996+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}